31 January 2021
3QFY21 Results Update | Sector: Capital Goods
Cummins India
Estimate change
TP change
Rating change
Bloomberg
Equity Shares (m)
M.Cap.(INRb)/(USDb)
52-Week Range (INR)
1, 6, 12 Rel. Per (%)
12M Avg Val (INR M)
Financials & Valuations (INR b)
Y/E Mar
2020 2021E
Sales
51.6
43.9
EBITDA
5.9
5.8
PAT
6.4
5.3
EBITDA (%)
11.4
13.2
EPS (INR)
23.3
19.0
EPS Gr. (%)
(10.8) (18.2)
BV/Sh. (INR)
150.6
160.4
Ratios
Net D/E
0.0
(0.1)
RoE (%)
15.4
11.9
RoCE (%)
14.0
10.8
Payout (%)
90.3
53.8
Valuations
P/E (x)
28.6
35.0
P/BV (x)
4.4
4.2
EV/EBITDA (x)
31.6
31.4
Div Yield (%)
2.5
1.4
FCF Yield (%)
2.0
1.9
KKC IN
184.8 / 2.4
689 / 282
20/45/-1
711
2022E
52.9
6.8
6.2
12.9
22.5
18.3
166.7
(0.0)
13.5
12.3
72.0
29.6
4.0
26.8
1.9
0.6
CMP: INR667
TP: INR515 (-23%)
Sell
Weak revenue (in-line); cost measures likely to persist
Promise of future technologies / corporate development may keep
valuations buoyant in near term, overlooking fundamentals
Cummins India (KKC)’s revenue growth was weak, in line with expectations.
It declined 2% YoY on a weak base (3QFY20: -3%) and could have been even
weaker if not for a large order in the Powergen segment. However,
persistent cost-cutting measures (employee cost and other expenses) led to
EBITDA margins of 17%. Adj. PAT was flat YoY at INR2b and was 8% ahead of
our expectation.
Revenue normalization is taking longer than expected (in line with our bearish
thesis), especially as exports also failed to cheer. Also, the coming quarters
would bear the brunt of commodity price inflation on gross margins. Notably,
the EBITDA margin surprise came from employee cost cuts and sharp decline
in other expenses (such as lower warranty provisions and royalty payments) –
not sustainable beyond the next 2–3 quarters, in our view.
(a) Management commentary/indications on likely future opportunities in
hydrogen fuel cell technologies for the listed entity and (b) no decline or
affirmation from management towards corporate development involving a
listed and unlisted entity merger may keep investors guessing on the
optionality. While we maintain our long-term thesis of structural issues in
the current business, valuations could remain buoyant in the medium term
on account of option value, especially as capex spending picks up hereafter.
We largely maintain our FY22/FY23E estimate, but increase the target
multiple to 20x (in line with the re-rating for the entire sector) and TP to
INR515. Maintain Sell.
Revenue declined 2% YoY to INR14.2b, in line with our expectation. Gross
profit was flat YoY at INR5.1bn, a minor miss of 3% against our expectation.
EBITDA increased 12% YoY to INR2.4b and was 13% ahead of our
expectation. The EBITDA margin came in at 17.0% (+220bp YoY) v/s our
expectation of 14.7%. This is attributable to 11.6% YoY decline in employee
cost and 6% decline YoY in other expenses.
Other income included an income tax refund of INR356m. Adjusted for the
same, other income declined 13% YoY to INR629m. Adj. PAT was flat at
INR2.0b and 8% ahead of our expectation.
Domestic sales declined 3% YoY to INR10.3b. The Powergen segment posted
11% growth on the back of a large order. Industrials and Distribution revenue
was down 4% YoY and 12% YoY, respectively. Exports grew 1% to INR3.7b.
KKC was not impacted by commodity price inflation in 3Q; however, strong
headwinds are expected in the coming quarter. It aims to mitigate input cost
risks by taking price hikes. However, end market demand remains uncertain;
hence, the company is still in the wait-and-watch mode and unable to
provide guidance.
277
Weak revenue growth (in-line), lower other expenses lead to surprise
Shareholding pattern (%)
As On
Promoter
DII
FII
Others
Dec-20 Sep-20 Dec-19
51.0
51.0
51.0
27.5
29.3
31.8
9.0
8.2
6.3
12.5
11.5
10.9
FII Includes depository receipts
Key management call highlights
Nilesh Bhaiya – Research Analyst
(Nilesh.Bhaiya@MotilalOswal.com)
Pratik Singh – Research Analyst
(Pratik.Singh@MotilalOswal.com)
Investors are advised to refer through important disclosures made at the last page of the Research Report.
Motilal Oswal research is available on www.motilaloswal.com/Institutional-Equities, Bloomberg, Thomson Reuters, Factset and S&P Capital.